Assisted Regeneration for Muscle Loss
hero_pattern.png

GenAssist Inc.

Providing a New Therapy for Muscle Trauma

 

The First Company to Restore Muscle

 

Today

Over 250,000 traumatic muscle injuries every year

60% of muscle trauma injuries are left untreated

>80% of delayed amputations are caused by muscle trauma

90% of medical military retirements are caused by muscle trauma

>$500,000 is the lifetime cost of disability after trauma

Tomorrow

Introducing MyoMatrix™

MyoMatrix™ is a scaffold technology made of natural extracellular matrix proteins. These special proteins are tightly bonded to create an optimized support system for muscle tissue.

In preclinical animal studies, MyoMatrix™ increased muscle strength by 52% only 4 weeks post-implantation with no physical therapy.

At 6 weeks after injury, MyoMatrix™ with simulated physical therapy increased muscle strength by an additional 52%.

WHAT THIS means: Genassist is the first company with the potential to end disability caused by untreated muscle trauma